The Chinese government took its economic sanctions against San Diego-based Illumina a step further Tuesday by banning the ...
Illumina navigates competition and geopolitical risks with improved margins and strong cash flow. Read my analysis of ILMN ...
GlobalData’s senior medical analyst says the ban will add to a downward trend for Illumina in the Chinese market.
The firm provides a broad range of instruments and related consumables ... Project completed in 2003 to $1,000 after Illumina introduced HiSeq X in early 2014. Further innovation, like the NovaSeq ...
The firm provides a broad range of instruments and related consumables ... Project completed in 2003 to $1,000 after Illumina introduced HiSeq X in early 2014. Further innovation, like the NovaSeq ...
Improvements in the new Illumina platform (HiSeq 2000) include reagent optimization ... which were positioned as instrument vendors, the Complete Genomics business model is to operate as a ...
San Diego–based Illumina garners the second and third spots with its latest sequencers, one of which (the third-place HiSeq X 10) achieves the long-awaited $1,000 human genome milestone. Other cool ...
Here are the biggest headlines of the day in the latest Market Minute. Illumina (ILMN) shares have recouped their losses. The stock had fallen after China banned it from exporting its gene ...
Massey Genome Service (MGS) has invested in two Illumina MiSeqâ„¢ instruments. We offer Illumina MiSeqâ„¢ sequencing with the following applications: Send the Massey Genome Service (MSG) an email about ...